References
- Juliusson G, Fau-Hough R, Hough R. Leukemia. Prog Tumor Res. 2016;43(1):87–100.
- An Q, Fan C-H, Xu S-M. Recent perspectives of pediatric leukemia – an update. Eur Rev Med Pharmacol Sci. 2017;21(4 Suppl.):31–36.
- Barth M, Raetz E Fau - Cairo MS, Cairo MS. The future role of monoclonal antibody therapy in childhood acute leukaemias. Br J Haematol. 2012;159(1):3–17. doi:https://doi.org/10.1111/bjh.12002.
- Liu W, Xiao K, Ren L, et al. Leukemia cells apoptosis by a newly discovered heterogeneous polysaccharide from Angelica sinensis (Oliv.) Diels. Carbohydr Polym. 2020;241:116279.
- Baell JB, Leaver DJ, Hermans SJ, et al. Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth. Nature. 2018;560(7717):253–257. doi:https://doi.org/10.1038/s41586-018-0387-5.
- Kennedy J, Goudie D, Blair E, The DDD Study, et al. KAT6A syndrome: genotype-phenotype correlation in 76 patients with pathogenic KAT6A variants. Genet Med. 2019;21(4):850–860., doi:https://doi.org/10.1038/s41436-018-0259-2.
- Turner-Ivey B, Guest ST, Irish JC, et al. KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer. Neoplasia. 2014;16(8):644–655. doi:https://doi.org/10.1016/j.neo.2014.07.007.
- Ye J, Luo D, Yu J, et al. Transcriptome analysis identifies key regulators and networks in Acute myeloid leukemia. Hematology. 2019;24(1):487–491. doi:https://doi.org/10.1080/16078454.2019.1631506.
- Zhang C, Bai G, Zhu W, et al. Identification of miRNA-mRNA network associated with acute myeloid leukemia survival. Med Sci Monit. 2017;23(1):4705–4714. doi:https://doi.org/10.12659/msm.903989.
- Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, et al. An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234(5):5451–5465. doi:https://doi.org/10.1002/jcp.27486.
- Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141(4):1202–1207. doi:https://doi.org/10.1016/j.jaci.2017.08.034.
- Schulte C, Karakas M, Zeller T. microRNAs in cardiovascular disease – clinical application. Clin Chem Lab Med. 2017;55(5):687–704. doi:https://doi.org/10.1515/cclm-2016-0576.
- Grasedieck S, Sorrentino A, Langer C, et al. Circulating microRNAs in hematological diseases: principles, challenges, and perspectives. Blood. 2013;121(25):4977–4984. doi:https://doi.org/10.1182/blood-2013-01-480079.
- Shi H, Shen H, Xu J, et al. MiR-143-3p suppresses the progression of ovarian cancer. Am J Transl Res. 2018;10(3):866–874.
- Sun X, Dai G, Yu L, et al. miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2. Sci Rep. 2018;8(1):606–606. doi:https://doi.org/10.1038/s41598-017-18739-3.
- Lv D, Jia F, Hou Y, et al. Histone acetyltransferase KAT6A upregulates PI3K/AKT signaling through TRIM24 binding. Cancer Res. 2017;77(22):6190–6201. doi:https://doi.org/10.1158/0008-5472.CAN-17-1388.
- Roberts I, Fordham NJ, Rao A, et al. Neonatal leukaemia. Br J Haematol. 2018;182(2):170–184. doi:https://doi.org/10.1111/bjh.15246.
- Chinen Y, Taki T, Tsutsumi Y, et al. The leucine twenty homeobox (LEUTX) gene, which lacks a histone acetyltransferase domain, is fused to KAT6A in therapy-related acute myeloid leukemia with t(8;19)(p11;q13). Genes Chromos Cancer. 2014;53(4):299–308. doi:https://doi.org/10.1002/gcc.22140.
- Sheikh BN, Phipson B, El-Saafin F, et al. MOZ (MYST3, KAT6A) inhibits senescence via the INK4A-ARF pathway. Oncogene. 2015;34(47):5807–5820. doi:https://doi.org/10.1038/onc.2015.33.
- Xie F, Li C, Zhang X, et al. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS. Biomed Pharmacother. 2019;119(1):109424. doi:https://doi.org/10.1016/j.biopha.2019.109424.
- Qian Y, Teng Y, Li Y, et al. MiR-143-3p suppresses the progression of nasal squamous cell carcinoma by targeting Bcl-2 and IGF1R. Biochem Biophys Res Commun. 2019;518(3):492–499. doi:https://doi.org/10.1016/j.bbrc.2019.08.075.
- Chen J, Chen X. MYBL2 is targeted by miR-143-3p and regulates breast cancer cell proliferation and apoptosis. Oncol Res. 2018;26(6):913–922. doi:https://doi.org/10.3727/096504017X15135941182107.